Publication: Invasive fungal diseases in children with acute leukemia and severe aplastic anemia
Issued Date
2021-06-01
Resource Type
ISSN
20353006
Other identifier(s)
2-s2.0-85109527262
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Mediterranean Journal of Hematology and Infectious Diseases. Vol.13, No.1 (2021)
Suggested Citation
Sutatta Supatharawanich, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Bunchoo Pongtanakul, Sasima Tongsai, Phakatip Sinlapamongkolkul, Popchai Ngamskulrungroj, Wanatpreeya Phongsamart, Kleebsabai Sanpakit, Jassada Buaboonnam Invasive fungal diseases in children with acute leukemia and severe aplastic anemia. Mediterranean Journal of Hematology and Infectious Diseases. Vol.13, No.1 (2021). doi:10.4084/MJHID.2021.039 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78133
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Invasive fungal diseases in children with acute leukemia and severe aplastic anemia
Other Contributor(s)
Abstract
Although the outcomes of childhood leukemia and severe aplastic anemia (SAA) have improved, infectious complications are still the major concern. Particularly worrisome are invasive fungal diseases (IFDs), one of the most common causes of infectious-related deaths in patients with prolonged neutropenia. A retrospective study was conducted of IFDs in pediatric patients with newly diagnosed or relapsed acute leukemia, or with SAA, at Siriraj Hospital, Mahidol University, Thailand. There were 241 patients: 150 with acute lymphoblastic leukemia (ALL), 35 with acute myeloid leukemia (AML), 31 with relapsed leukemia, and 25 with SAA. Their median age was 5.4 years (range, 0.3-16.0 years). The overall IFD prevalence was 10.7%, with a breakdown in the ALL, AML, relapsed leukemia, and SAA patients of 8%, 11.4%, 19.3%, and 16%, respectively. Pulmonary IFD caused by invasive aspergillosis was the most common, accounting for 38.5% of all infection sites. Candidemia was present in 34.6% of the IFD patients; Candida tropicalis was the most common organism. The overall case-fatality rate was 38.5%, with the highest rate found in relapsed leukemia (75%). The incidences of IFDs in patients with relapsed leukemia and SAA who received fungal prophylaxis were significantly lower than in those who did not (P = N/A and 0.04, respectively). IFDs in Thai children with hematological diseases appeared to be prevalent, with a high fatality rate. The usage of antifungal prophylaxes should be considered for patients with SAA to prevent IFDs.
